Skip to main content
    C

    Corvex, Inc. (MOVE)

    Official site

    TECHNOLOGY • MEDICAL DEVICES • NASDAQ

    $4.70
    +0.23 (+5.15%)

    Market Cap: $174.95M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Corvex, Inc. (MOVE) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2026. Financial statements from company filings, amounts in US dollars.

    Corvex reported revenue of $433.00K for the fiscal year ended Dec 31, 2025, down 57.3% from the year before. That year, net income was -$18.29M with a net margin of -4222.9%, operating cash flow was -$11.27M and free cash flow was -$11.27M. The quarter ended Sep 30, 2026 had revenue of $4.98M and net income of -$17.52M.

    Revenue and Margins

    Over the 13 years to Dec 2025, revenue fell from $199.23M, a compound annual decline of 37.6%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$433.00K-57.3%-424.9%-3580.4%-4222.9%
    Dec 2024$1.01MN/A-196.8%-2391.1%-2342.3%
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Dec 2020$0N/AN/AN/AN/A
    Dec 2019$0N/AN/AN/AN/A
    Dec 2018N/AN/AN/AN/AN/A
    Dec 2013$227.03M+14.0%84.4%0.2%0.3%
    Dec 2012$199.23MN/A84.0%2.6%2.8%
    Annual, fiscal years ended Dec 2012 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2013Dec 2012
    Revenue$433.00K$1.01M$0$0$0$0$0N/A$227.03M$199.23M
    Cost of revenue$2.27M$3.01M$0$0$0$0$11.00K$3.00K$35.36M$31.86M
    Gross profit-$1.84M-$1.99M$0$0$0$0-$11.00K-$3.00K$191.67M$167.37M
    Research and development$5.74M$11.20M$16.89M$18.99M$13.43M$8.37M$6.51M$2.89M$38.89M$37.34M
    Operating income-$15.50M-$24.22M-$29.69M-$30.46M-$19.80M-$11.11M-$8.51M-$3.50M$561.00K$5.25M
    Net income-$18.29M-$23.73M-$29.28M-$30.33M-$21.77M-$13.03M-$8.44M-$3.49M$574.00K$5.63M
    EBITDA-$12.29M-$23.56M-$29.13M-$30.21MN/AN/A-$8.43M-$3.48MN/AN/A
    Fiscal years ended Dec 2012 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$4.98M$3.80M$510.00K$44.00K$80.00K$103.00K$206.00K$111.00K$50.00K$0$852.00K$0
    Gross profit$2.46M$1.68M-$2.00K-$945.00K-$200.00K-$259.00K-$436.00K-$456.00K-$795.00K-$380.00K-$363.00KN/A
    Operating income-$17.44M-$15.22M-$4.85M-$4.41M-$2.59M-$3.26M-$5.24M-$4.69M-$7.38M-$6.40M-$5.75M-$6.02M
    Net income-$17.52M-$12.77M-$5.00M-$5.85M-$4.03M-$3.23M-$5.18M-$4.62M-$7.20M-$6.19M-$5.72M-$6.18M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $4.38M exceeded cash and equivalents by $1.55M. Shareholder equity was negative, at -$3.47M, as total liabilities of $9.07M exceeded total assets of $5.60M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2013Dec 2012
    Total assets$5.60M$11.32M$9.42M$13.24M$36.27M$7.08M$4.89M$3.40M$236.79M$136.87M
    Current assets$4.99M$10.39M$8.52M$11.65M$35.06M$6.90M$4.51M$3.17MN/AN/A
    Cash and equivalents$2.83M$7.90M$6.12M$10.76M$17.68M$5.71M$4.29M$3.17M$118.68M$27.12M
    Total liabilities$9.07M$3.96M$5.97M$5.33M$3.54M$15.14M$890.00K$391.00K$127.96M$38.86M
    Short-term debt$4.38M$0$217.00K$212.00KN/A$248.00KN/AN/AN/AN/A
    Long-term debt$0N/AN/AN/AN/A$11.34MN/AN/A$82.46MN/A
    Shareholder equity-$3.47M$7.36M$3.45M$7.92M$32.73M-$40.88M$4.00M$3.01M$108.83M$98.01M
    Fiscal years ended Dec 2012 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$627.69M$599.32M$604.48M$5.60M$5.56M$5.66M$7.77M$11.32M$15.07M$20.83M$5.13M$9.42M
    Total liabilities$29.34M$26.07M$28.48M$9.07M$7.26M$4.02M$4.53M$3.96M$4.82M$4.05M$6.61M$5.97M
    Cash and equivalents$41.99M$21.70M$29.33M$2.83M$2.00M$2.11M$4.36M$7.90M$11.27M$16.87M$2.15M$6.12M
    Shareholder equity$598.35M$573.25M$576.00M-$3.47M-$1.70M$1.64M$3.23M$7.36M$10.25M$16.78M-$1.48M$3.45M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow-$11.27M-$22.53M-$26.18M-$24.90M-$16.18M-$10.67M-$8.23M-$3.28M
    Capital expenditures$0$8.00K$64.00K$105.00K$565.00K$0$13.00K$52.00K
    Free cash flow-$11.27M-$22.54M-$26.24M-$25.01M-$16.75M-$10.67M-$8.24M-$3.33M
    Share repurchasesN/AN/AN/AN/AN/A$695.00KN/AN/A
    Investing cash flow$0-$8.00K-$64.00K$15.72M-$16.70M$0-$13.00K-$52.00K
    Financing cash flow$6.19M$24.32M$21.60M$2.26M$44.85M$12.09M$9.36M$6.50M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$7.00M-$5.27M-$4.29M-$2.26M-$1.61M-$3.10M-$4.30M-$4.55M-$5.67M-$8.17M-$4.13M-$5.25M
    Capital expenditures$9.77M$652.00K$6.24M$894.00K$5.00K$5.00K$0$5.00K$3.00K$0$6.00K$13.00K
    Free cash flow-$16.78M-$5.93M-$10.53M-$3.15M-$1.61M-$3.10M-$4.30M-$4.56M-$5.68M-$8.17M-$4.14M-$5.26M
    Last 12 quarters

    Frequently Asked Questions About MOVE

    What is Corvex's annual revenue?

    Corvex reported revenue of $433.00K for the fiscal year ended Dec 31, 2025.

    How fast is Corvex's revenue growing?

    Revenue was down 57.3% for the fiscal year ended Dec 31, 2025 compared with the year before.

    Is Corvex profitable?

    No. Corvex reported net income of -$18.29M for the fiscal year ended Dec 31, 2025, with a net margin of -4222.9%.

    How much free cash flow does MOVE generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$11.27M minus capital expenditures of $0 produced free cash flow of -$11.27M.

    How much debt does Corvex have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $0, short-term debt of $4.38M and cash and equivalents of $2.83M.